4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-22-004408
CHIEF EXECUTIVE OFFICER bought 20,000 shares at $2.34 ($46,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2022-06-16 | Purchase | +20,000 | $2.34 | $46,800 | 5,311,873 | D |
| Open-market purchases · 20,000 sh · avg $2.34 · $46,800 | |||||||
Loading xslF345X03/ownership.xml…